Tranexamic acid is a synthetic derivative of the amino acid lysine.
Tranexamic acid is an antifibrinolytic that competitively inhibits the activation of plasminogen to plasmin, a molecule
responsible for the degradation of fibrin. Tranexamic acid has roughly 8 times the antifibrinolytic activity of an older analogue, ε-aminocaproic acid.